Viewing Study NCT07343960


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-30 @ 2:43 AM
Study NCT ID: NCT07343960
Status: RECRUITING
Last Update Posted: 2026-02-24
First Post: 2026-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module